Article
Limited sampling strategy to predict AUC of the CYP3A phenotyping probe midazolam in adults: application to various assay techniques.
Journal of clinical pharmacology - 1 Apr 2002
Kim Jooran S, Nafziger Anne N, Tsunoda Shirley M, Choo Edna E, Streetman Daniel S, Kashuba Angela D M, Kulawy Robert W, Beck Debra J, Rocci Mario L, Wilkinson Grant R, Greenblatt David J, Bertino Joseph S
Abstract excerpt
Midazolam clearance is used to phenotype hepatic CYP3A activity but requires multiple plasma samples following a single intravenous dose. The authors evaluated the use of a limited sampling scheme, using different assay techniques to determine the reproducibility of such a strategy in estimating midazolam AUC. Seventy-three healthy adults received midazolam as a single intravenous bolus dose. At least eight...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
